Oyster Point Pharma, Inc. is an American

biopharmaceutical A biopharmaceutical, also known as a biological medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Different from totally synthesized pharmaceuticals, t ...

based in

Princeton, New Jersey Princeton is a municipality with a borough form of government in Mercer County, in the U.S. state of New Jersey. It was established on January 1, 2013, through the consolidation of the Borough of Princeton and Princeton Township, both of whi ...

, focusing on the development of pharmaceutical therapies to treat ophthalmic diseases.

Products

The lead product of the company is Tyrvaya. In October 2021, it was the first nasal spray approved by

Food and Drug Administration The United States Food and Drug Administration (FDA or US FDA) is a List of United States federal agencies, federal agency of the United States Department of Health and Human Services, Department of Health and Human Services. The FDA is respon ...

to treat

dry eye syndrome Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. Symptoms range ...

Initial public offering and stock history

Prior to going public, Oyster Point Pharma operated at a loss of $16.5 million in 2018. In February 2019, still at clinical stage, the company raised $93 million in its

Series B A venture round is a type of funding round used for venture capital financing, by which startup companies obtain investment, generally from venture capitalists and other institutional investors. The availability of venture funding is among the ...

funding round. In October 2019, the company issued 5-million shares in the initial public offering with

NASDAQ Global Select Market The Nasdaq Stock Market () (National Association of Securities Dealers Automated Quotations Stock Market) is an American stock exchange based in New York City. It is the most active stock trading venue in the US by volume, and ranked second ...

at the price of $16 per share with the first trading day on October 31.

References

External links

* {{Official website, http://www.oysterpointrx.com Companies listed on the Nasdaq Biotechnology companies of the United States Pharmaceutical companies based in New Jersey Companies based in Princeton, New Jersey Companies established in 2015